F. Andersohn

First name

F.

Last name

Andersohn

Andersohn, F., Suissa, S., & Garbe, E. (2006). Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation. http://doi.org/10.1161/circulationaha.105.602425

View

Andersohn, F., Schade, R., Suissa, S., & Garbe, E. (2006). Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. Stroke. http://doi.org/10.1161/01.str.0000226642.55207.94

View

Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., & Garbe, E. (2007). Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med. http://doi.org/10.1056/NEJMoa062222

View

Andersohn, F., Schade, R., Willich, S. N., & Garbe, E. (2010). Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology. http://doi.org/10.1212/WNL.0b013e3181ea157e

View

Andersohn, F., Schade, R., Suissa, S., & Garbe, E. (2009). Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry. http://doi.org/10.1176/appi.ajp.2008.08071065

View

Andersohn, F., Waring, M., & Garbe, E. (2010). Risk of ischemic stroke in patients with Crohn\textquoterights disease: a population-based nested case-control study. Inflamm Bowel Dis. http://doi.org/10.1002/ibd.21187

View

Cooper, A. J. M., Willis, J., Fuller, J., Benecke, H., Leighton-Scott, J., Andersohn, F., et al. (2017). Prevalence and Incidence Trends for Diagnosed Prescription Opioid Use Disorders in the United Kingdom. Pain Ther. http://doi.org/10.1007/s40122-017-0070-9

View

Conradt, C., Guo, D., Miclea, A., Nisslein, T., Ismail, C., Chatamra, K., & Andersohn, F. (2018). Increased Prevalence of Polyneuropathy in Parkinson\textquoterights Disease Patients: An Observational Study. J Parkinsons Dis. http://doi.org/10.3233/jpd-161057

View